Delivery Order SPE2DR25D1017-SPE2DR26F9ECK
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $9,236.74 to AmerisourceBergen Drug Corp for the supply of Sotyktu 6 mg tablets (30-count units) on January 14, 2026, with a completion date of February 5, 2026. This non-competitive delivery order is being fulfilled from the company's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a task order issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $9,236.74 to AmerisourceBergen Drug Corp for the supply of Sotyktu 6 mg tablets (30-count units) on January 8, 2026, with an ultimate completion date of January 30, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of...
- The Defense Logistics Agency awarded a $4,618.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Sotyktu 6 mg tablets (30-count packaging). This competitive award, with an ultimate completion date of January 28, 2026, represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Sotyktu 6 mg tablets (30-count units) under a firm fixed-price contract. The delivery order, valued at $9,236.74 with a completion date of January 27, 2026, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $4,618.36 to AmerisourceBergen Drug Corp for the supply of Sotyktu 6 mg tablets (30-count units) on January 22, 2026, with an ultimate completion date of February 12, 2026. This firm fixed-price, non-set-aside contract is to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for Sotyktu 6 mg tablets (30-count supply) valued at $4,338.49. This firm fixed-price delivery order, with an ultimate completion date of December 5, 2025, was competitively awarded with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $27,710.16 to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 14, 2026, for the supply of Sotyktu 6 mg tablets in quantities of 30 units. The contract is firm fixed price with no set-aside designation, indicating competitive award. Performance will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of February 5, 2026. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $4,338.49 to AmerisourceBergen Drug Corp for the supply of Sotyktu 6 mg tablets (30-count) on December 18, 2025, with a completion date of January 12, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,618.36 to AmerisourceBergen Drug Corp for the supply of Sotyktu 6 mg tablets (30-count packaging) on January 28, 2026, with an ultimate completion date of February 19, 2026. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's parent company, Cencora, Inc., and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded...
- The Defense Logistics Agency (DLA) awarded a $8,676.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sotyktu 6 mg tablets (30-count units) on November 6, 2025, with performance to be completed by December 1, 2025. The award was made on a non-set-aside basis through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city....
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9ECKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,236.74 to AmerisourceBergen Drug Corp for the supply of Sotyktu 6 mg tablets (30-count units) under a firm fixed-price contract. This delivery order, awarded on January 30, 2026, with an ultimate completion date of February 23, 2026, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this award. The performance location is also identified as Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. This comprehensive IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The award reflects the company's demonstrated capability to fulfill federal procurement requirements for essential pharmaceutical products required by military treatment facilities and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 1/29/26 |